NO137233C - Analogifremgangsm}te for fremstilling av terapeutisk aktive alfa, alfa-diarylimidazol-2-metanoler og syreaddisjonssalter derav - Google Patents
Analogifremgangsm}te for fremstilling av terapeutisk aktive alfa, alfa-diarylimidazol-2-metanoler og syreaddisjonssalter deravInfo
- Publication number
- NO137233C NO137233C NO442/73A NO44273A NO137233C NO 137233 C NO137233 C NO 137233C NO 442/73 A NO442/73 A NO 442/73A NO 44273 A NO44273 A NO 44273A NO 137233 C NO137233 C NO 137233C
- Authority
- NO
- Norway
- Prior art keywords
- alfa
- diarylimidazole
- methanols
- preparation
- therapeutic active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB541872 | 1972-02-04 | ||
| GB541872A GB1363382A (en) | 1972-02-04 | 1972-09-05 | Alpha.alpha-diarylimidazole-2-methanols |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO137233B NO137233B (no) | 1977-10-17 |
| NO137233C true NO137233C (no) | 1978-01-25 |
Family
ID=26239878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO442/73A NO137233C (no) | 1972-02-04 | 1973-02-02 | Analogifremgangsm}te for fremstilling av terapeutisk aktive alfa, alfa-diarylimidazol-2-metanoler og syreaddisjonssalter derav |
Country Status (16)
| Country | Link |
|---|---|
| AT (1) | AT322545B (hu) |
| AU (1) | AU467008B2 (hu) |
| BE (1) | BE794940A (hu) |
| CA (1) | CA979899A (hu) |
| CH (1) | CH594630A5 (hu) |
| CS (1) | CS187368B2 (hu) |
| DE (1) | DE2305212A1 (hu) |
| ES (1) | ES411222A1 (hu) |
| FI (1) | FI57936C (hu) |
| FR (1) | FR2173984B1 (hu) |
| GB (1) | GB1363382A (hu) |
| HU (1) | HU166406B (hu) |
| IL (1) | IL41448A (hu) |
| LU (1) | LU66953A1 (hu) |
| NL (1) | NL7301494A (hu) |
| NO (1) | NO137233C (hu) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19951701A1 (de) * | 1999-10-27 | 2001-05-03 | Aventis Pharma Gmbh | Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten |
| US8063090B2 (en) * | 2007-03-23 | 2011-11-22 | Merck Sharp & Dohme Corp. | Mineralocorticoid receptor modulators |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2899441A (en) * | 1959-08-11 | Chjchjoh |
-
0
- BE BE794940D patent/BE794940A/xx unknown
-
1972
- 1972-09-05 GB GB541872A patent/GB1363382A/en not_active Expired
-
1973
- 1973-02-02 IL IL41448A patent/IL41448A/en unknown
- 1973-02-02 CS CS73810A patent/CS187368B2/cs unknown
- 1973-02-02 DE DE2305212A patent/DE2305212A1/de not_active Ceased
- 1973-02-02 FI FI325/73A patent/FI57936C/fi active
- 1973-02-02 LU LU66953A patent/LU66953A1/xx unknown
- 1973-02-02 NL NL7301494A patent/NL7301494A/xx not_active Application Discontinuation
- 1973-02-02 NO NO442/73A patent/NO137233C/no unknown
- 1973-02-02 HU HUGI187A patent/HU166406B/hu unknown
- 1973-02-02 FR FR7303708A patent/FR2173984B1/fr not_active Expired
- 1973-02-02 ES ES411222A patent/ES411222A1/es not_active Expired
- 1973-02-02 CH CH148373A patent/CH594630A5/xx not_active IP Right Cessation
- 1973-02-02 AT AT91473A patent/AT322545B/de not_active IP Right Cessation
- 1973-02-02 AU AU51774/73A patent/AU467008B2/en not_active Expired
- 1973-02-02 CA CA162,792A patent/CA979899A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU467008B2 (en) | 1975-11-13 |
| FR2173984A1 (hu) | 1973-10-12 |
| GB1363382A (en) | 1974-08-14 |
| NO137233B (no) | 1977-10-17 |
| IL41448A0 (en) | 1973-04-30 |
| CS187368B2 (en) | 1979-01-31 |
| AT322545B (de) | 1975-05-26 |
| CA979899A (en) | 1975-12-16 |
| FR2173984B1 (hu) | 1976-08-13 |
| FI57936C (fi) | 1980-11-10 |
| CH594630A5 (hu) | 1978-01-13 |
| NL7301494A (hu) | 1973-08-07 |
| LU66953A1 (hu) | 1973-04-19 |
| BE794940A (fr) | 1973-08-02 |
| AU5177473A (en) | 1974-08-08 |
| FI57936B (fi) | 1980-07-31 |
| DE2305212A1 (de) | 1973-08-16 |
| ES411222A1 (es) | 1975-12-01 |
| IL41448A (en) | 1977-07-31 |
| HU166406B (hu) | 1975-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO140381C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner | |
| NO138807C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivr e 3-merkaptotiadiazol- eller merkaptotetrazol-cefalosporine | |
| NO137321C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive 3-okso-17alfa-acyloksyandrost-4-en-17beta-karboksylsyreestere | |
| NO136459C (no) | Analogifremgangsm}te for fremstilling av antimikrobielt virksomme pleuromutiliner. | |
| NO138566C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater | |
| NO138374C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-fenoksyfenoksyalkankarboksylsyrederivater | |
| NO143575C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater | |
| NO136492C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive 3-(trisubstituert benzoyl)-propionsyre. | |
| NO140977C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner | |
| NO138999C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner | |
| NO137899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider | |
| NO136251C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater. | |
| SE400551B (sv) | Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat | |
| NO137858C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner | |
| NO139088C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner | |
| NO139917C (no) | Analogifremgangsmaate for fremstilling av 1-aminometyl-2,2-diaryl-cyklopropankarboksamider og salter derav | |
| NO136795C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive indoliner | |
| NO138025C (no) | Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler | |
| NO137728C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater | |
| NO138598C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-(2-delta2-imidazolinyl)-2,2-diarylcyklopropaner og deres syreaddisjonssalter | |
| NO137233C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive alfa, alfa-diarylimidazol-2-metanoler og syreaddisjonssalter derav | |
| SE403612B (sv) | Analogiforfarande for framstellning av antibakteriellt aktiva hexametylen-bis-biguanider | |
| NO137695C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser | |
| NO136410C (no) | Analogifremgangsm}te til fremstilling av antidiabetisk virksomme 3-metyl-pyrazol-5-karboksamider. | |
| NO139173C (no) | Analogifremgangsmaate for fremstilling av antimikrobielt aktive 2-kinoksalin-karboksamid-1,4-dioksyder |